NDC 50242-108 – Rituxan Hycela
Rituximab 120 mg/mL; Hyaluronidase (human Recombinant) 2000 U/mL · Injection, Solution · Subcutaneous
Product NDC50242-108
Product details
- Brand name
- Rituxan Hycela
- Generic name
- Rituximab and hyaluronidase
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761064
- Marketed since
- June 22, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- CD20-directed Cytolytic Antibody; Endoglycosidase
Active ingredients
- Rituximab 120 mg/mL
- Hyaluronidase (human Recombinant) 2000 U/mL
Uses, dosage, side effects and warnings for Rituxan Hycela →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 50242-108-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-108-01) / 11.7 mL in 1 VIAL, SINGLE-DOSE | Jun 22, 2017 |
| 50242-108-86 sample | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-108-86) / 11.7 mL in 1 VIAL, SINGLE-DOSE | Jun 23, 2017 |
Other Rituxan Hycela products
- 50242-109 Rituximab 120 mg/mL; Hyaluronidase (human Recombinant) 2000 U/mL · Injection, Solution · Genentech, Inc.